Tablet
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a side perspective view of a tablet showing our new design;
FIG. 2 is a rear elevational view thereof;
FIG. 3 is a top plan view thereof;
FIG. 4 is a bottom plan view thereof;
FIG. 5 is a front elevational view thereof;
FIG. 6 is a left side view, the right side view being a mirror image thereof;
FIG. 7 is a side perspective view of a second embodiment thereof;
FIG. 8 is a rear elevational view thereof;
FIG. 9 is a top plan view thereof;
FIG. 10 is a bottom plan view thereof;
FIG. 11 is a front elevational view thereof; and
FIG. 12 is a left side view, the right side view being a mirror image thereof.
Referenced Cited
Patent History
Patent number: D316615
Type: Grant
Filed: Oct 19, 1988
Date of Patent: Apr 30, 1991
Assignee: Glaxo Group Limited (London)
Inventors: Peter J. Rue (Little Hallingbury), Glenda Spray (Long Eaton), Fiona R. Bird (Welwyn)
Primary Examiner: Susan J. Lucas
Assistant Examiner: M. H. Tung
Law Firm: Darby & Darby
Application Number: 7/259,602
Type: Grant
Filed: Oct 19, 1988
Date of Patent: Apr 30, 1991
Assignee: Glaxo Group Limited (London)
Inventors: Peter J. Rue (Little Hallingbury), Glenda Spray (Long Eaton), Fiona R. Bird (Welwyn)
Primary Examiner: Susan J. Lucas
Assistant Examiner: M. H. Tung
Law Firm: Darby & Darby
Application Number: 7/259,602
Classifications
Current U.S. Class:
D28/2